| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf8373f3013dca535a8f1ad5458725f6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-626
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 |
| filingDate |
2005-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c5e5b06bd67b26994db301b978baca5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_065d1860944e2d6ff60ce9081cf3119b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6d7d31fd9ebdf099d023f996be59161
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6a052d78d4f1d6fa9eb25fd1c3b25be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06949966489817a3efecaeffeb45cdf2 |
| publicationDate |
2006-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1726650-A1 |
| titleOfInvention |
Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen |
| abstract |
Isolated monoclonal antibodies or an antigen binding portion thereof which bind to prostate specific membrane antigen in its native form occurring on the surface of tumor cells characterized in that it is linked to a label or a cytotoxic agent or constructed as a part of a bispecific antibody or a recombinant diabody. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8703918-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009130575-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009019493-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11352426-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9782478-B1 |
| priorityDate |
2005-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |